Yan Y - Search Results

1

A tetravalent single chain diabody (CD40/HER2) efficiently inhibits tumor proliferation through recruitment of T cells and anti-HER2 functions.

Lu L, Liu N, Fan K, Zhang G, Li C, Yan Y, Liu T, Fu WH. Lu L, et al. Among authors: yan y. Mol Immunol. 2019 May;109:149-156. doi: 10.1016/j.molimm.2019.03.001. Epub 2019 Apr 2. Mol Immunol. 2019. PMID: 30951934

2

HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis.

Yan Y, Lu L, Liu C, Li W, Liu T, Fu W. Yan Y, et al. Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):121-6. doi: 10.1016/j.clinre.2014.06.019. Epub 2014 Aug 28. Clin Res Hepatol Gastroenterol. 2015. PMID: 25176587

3

Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.

Yan Y, Lu N, Tian W, Liu T. Yan Y, et al. Tumori. 2014 Nov-Dec;100(6):e250-6. doi: 10.1700/1778.19288. Tumori. 2014. PMID: 25688507

4

Mesenchymal stem cell expression of interleukin-35 protects against ulcerative colitis by suppressing mucosal immune responses.

Yan Y, Zhao N, He X, Guo H, Zhang Z, Liu T. Yan Y, et al. Cytotherapy. 2018 Jul;20(7):911-918. doi: 10.1016/j.jcyt.2018.05.004. Epub 2018 Jun 12. Cytotherapy. 2018. PMID: 29907361

5

Selection and expression of CD40 single chain variable fragment by phage display and evaluation of tumor specific immune activation.

Lu L, Wang X, Zhang A, Huang F, Yan Y, Li W, Fu W. Lu L, et al. Among authors: yan y. Int Immunopharmacol. 2019 Jun;71:224-232. doi: 10.1016/j.intimp.2019.03.020. Epub 2019 Mar 26. Int Immunopharmacol. 2019. PMID: 30925323

6

Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched Study.

Yan Y, Yang A, Lu L, Zhao Z, Li C, Li W, Chao J, Liu T, Fong Y, Fu W, Woo Y. Yan Y, et al. Ann Surg Oncol. 2021 Mar;28(3):1428-1436. doi: 10.1245/s10434-020-09070-9. Epub 2020 Aug 29. Ann Surg Oncol. 2021. PMID: 32862371

7

Optimal Reconstruction After Laparoscopic Distal Gastrectomy: A Single-Center Retrospective Study.

Yan Y, Wang D, Liu Y, Lu L, Wang X, Zhao Z, Li C, Liu J, Li W, Fu W. Yan Y, et al. Cancer Control. 2022 Jan-Dec;29:10732748221087059. doi: 10.1177/10732748221087059. Cancer Control. 2022. PMID: 35412845 Free PMC article.

8

Different Methods of Minimally Invasive Esophagojejunostomy After Total Gastrectomy for Gastric Cancer: Outcomes from Two Experienced Centers.

Yan Y, Wang D, Mahuron K, Wang X, Lu L, Zhao Z, Melstrom L, Li C, Paz IB, Liu J, Fong Y, Li W, Fu W, Woo Y. Yan Y, et al. Ann Surg Oncol. 2023 Oct;30(11):6718-6727. doi: 10.1245/s10434-023-13771-2. Epub 2023 Jul 13. Ann Surg Oncol. 2023. PMID: 37442910 Free PMC article.

9

[No title available]

[No authors listed] [No authors listed] PMID: 37488396

10

Comparison of SOX and CAPOX in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: A randomized controlled trial.

Liu X, Yan Y, Lu L, Liu Y, Ma J, Wang X, Wang D, Liu B, Liu Z, Zhou X, Cui H, Zhao Z, Li C, Liu J, Li W, Huang QX, Zhao Q, Liu T, Fu W. Liu X, et al. Among authors: yan y. Cancer Med. 2024 Jun;13(11):e7326. doi: 10.1002/cam4.7326. Cancer Med. 2024. PMID: 38826114 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,745 results

Search Page

Filters